Medical economics

German pharma Merck makes bid for US group Versum

German pharmaceutical group Merck KgaA said Wednesday it had offered to buy electronics industry supplier Versum Materials for 5.3 billion euros ($6 billion), its biggest purchase in four years.


Merck posts strong first-quarter profit, but revenue light

Drugmaker Merck's first-quarter revenue rose 6 percent, driven by a huge jump in sales of cancer blockbuster Keytruda, but a $1.4 billion charge for starting a research partnership with Japanese drugmaker Eisai dragged down ...

Alzheimer's disease & dementia

Merck halts trial of once 'promising' Alzheimer's drug

US pharmaceutical giant Merck announced it is halting a clinical trial on a drug once touted as a promising treatment for Alzheimer's disease, saying studies show it does not work.


Jury orders Gilead to pay Merck $2.5bn in patent case

A US jury has ordered pharmaceutical giant Gilead Sciences to pay $2.5 billion to competitor Merck in a patent infringement case involving a drug used to treat hepatitis C, the two companies said.

page 1 from 14